Add to ORKGThe influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patient
Introduction: Anemia is a frequent condition in patients with chronic kidney disease due to a reduct...
Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population ...
Background. Hepcidin is a central regulator of iron ho-meostasis. Increased hepcidin concentrations ...
iron-gluconate during haemodialysis modifies plasma b2-microglobulin properties and level
Background. Iron supplementation is a mainstay for management of renal anaemia in patients receiving...
Introduction: Prohepcidin is the precursor of hepcidin, a liver-derived peptide involved in iron met...
Impact of elevated C-reactive protein levels on erythropoiesis-stimulating agent (ESA) dose and resp...
Abstract Background Hepcidin, an acute phase reactant released from the liver, suppresses intestinal...
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin ...
Background. Pentraxins are mediators of inflammation as well as markers of the acute-phase reaction....
Background: Patients with chronic HCV infection have increased liver iron. Recently identified prote...
osteoprotegerin levels and the extent of vascular calcification in haemodialysis patient
"nBackground: Prohepcidin, a liver-derived peptide with antimicrobial properties, is regulated ...
of iron treatment on immune effector function and cellular iron status of circulating monocytes in d...
SECONDARY HYPERPARATHYROIDISM (SHP) is one of the most serious complications occurring in maintenanc...
Introduction: Anemia is a frequent condition in patients with chronic kidney disease due to a reduct...
Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population ...
Background. Hepcidin is a central regulator of iron ho-meostasis. Increased hepcidin concentrations ...
iron-gluconate during haemodialysis modifies plasma b2-microglobulin properties and level
Background. Iron supplementation is a mainstay for management of renal anaemia in patients receiving...
Introduction: Prohepcidin is the precursor of hepcidin, a liver-derived peptide involved in iron met...
Impact of elevated C-reactive protein levels on erythropoiesis-stimulating agent (ESA) dose and resp...
Abstract Background Hepcidin, an acute phase reactant released from the liver, suppresses intestinal...
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin ...
Background. Pentraxins are mediators of inflammation as well as markers of the acute-phase reaction....
Background: Patients with chronic HCV infection have increased liver iron. Recently identified prote...
osteoprotegerin levels and the extent of vascular calcification in haemodialysis patient
"nBackground: Prohepcidin, a liver-derived peptide with antimicrobial properties, is regulated ...
of iron treatment on immune effector function and cellular iron status of circulating monocytes in d...
SECONDARY HYPERPARATHYROIDISM (SHP) is one of the most serious complications occurring in maintenanc...
Introduction: Anemia is a frequent condition in patients with chronic kidney disease due to a reduct...
Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population ...
Background. Hepcidin is a central regulator of iron ho-meostasis. Increased hepcidin concentrations ...